Elevating the level of hypoxia inducible factor may be a new potential target for the treatment of depression
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Medical Hypotheses
- Vol. 146, 110398
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
This publication has 76 references indexed in Scilit:
- Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?Neuroscience & Biobehavioral Reviews, 2012
- Hypoxia-Inducible Factors in Physiology and MedicineCell, 2012
- Role of vascular endothelial growth factor in adult hippocampal neurogenesis: Implications for the pathophysiology and treatment of depressionBehavioural Brain Research, 2012
- Hypoxia-inducible factor 1: Regulator of mitochondrial metabolism and mediator of ischemic preconditioningBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Astrocyte-Neuron Lactate Transport Is Required for Long-Term Memory FormationCell, 2011
- Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's diseaseThe Lancet Neurology, 2011
- Chronic Creatine Supplementation Alters Depression-like Behavior in Rodents in a Sex-Dependent MannerNeuropsychopharmacology, 2009
- Vascular endothelial growth factor prevents G93A‐SOD1‐induced motor neuron degenerationDevelopmental Neurobiology, 2009
- Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase PathwayMolecular Cell, 2008
- VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressantsProceedings of the National Academy of Sciences, 2007